To assess neuroprotective effects in the BD mouse model, CLN2 KO mice (1 month old, N = 6) were treated with EV-TPP1 two times a week for three weeks with EV-TPP1 through i.v. or i.p. This evidence concerns the gene TPP1 and Behcet disease.